Professor, Director of the Division of Biostatistics & Medical Informatics, Department of Epidemiology and Public Health, University of Maryland - Baltimore. Adjunct professor University of Copenhagen, Denmark. 20+ awards and honors incl. ESTRO Gold Medal, MD Anderson Distinguished Alumnus Award, Honorary Life member Assoc. of Radiation Oncologists of India & Belgian Soc. for Therapeutic Radiology and Oncology. 370+ publications, H-index 62 Web of Science.
Chris Brown is a clinical trial bio-statistician at the NHMRC Clinical Trails Centre at the University of Sydney. His main area of expertise is in oncology trials but also has experience in cardiology and neonatal research. His main areas of research are in pharmacoepidemiology and statistical methods.
Associate Professor Biostatistics and Informatics Colorado School of Public Health; Associate Chair for Research Biostatistics and Informatics; Director Colorado Biostatistics Consortium; Director Clinical and Translational Science Institute Biostatistics, Epidemiology and Research Design Program; Theme Chair, Biostatistics Special Interest Group, Association for Clinical and Translational Science
Gary has research interests primarily focussed on statistical (and reporting) aspects in developing and validating multivariable prediction models. He has published over 100 papers on clinical trials, observational studies, systematic reviews, quality of life, propensity scores and prediction models.
Gary is a statistical editor ("hanging committee") for the BMJ.
Gary also led the development of the TRIPOD Statement for reporting clinical prediction models - www.tripod-statement.org.
Dr Martin Daumer: Director of the SLCMSR e.v. - The Human Motion Institute in Munich and managing director of the IT company, Trium Analysis Online GmbH. He is also visiting lecturer for Telemedicine and Clinical Applications of Computational Medicine at the Technical University Munich.
Dr Daumer received a diploma in Physics in 1990 and a Ph.D. in mathematics from the Ludwig-Maximilians-University Munich in 1995, after having worked at CERN, Switzerland, and Rutgers University, USA.
A/Professor and Principal Research Fellow, Menzies School of Health Research, Darwin Australia
Infectious Diseases Physician at John Hunter Hospital and Conjoint Professor of Medicine and Public Health at the University of Newcastle, Australia.
Vice President of the Australasian Society for Infectious Diseases
Dr José Derraik was born in Rio de Janeiro (Brazil), but moved to New Zealand in 1995. José has a very broad academic background, with a BSc and MSc in Ecology from the University of Otago (New Zealand), and a PhD in Public Health (University of Otago). His MSc examined invertebrate biodiversity in human-modified habitats. His PhD focused on vector ecology, more precisely on mosquitoes in New Zealand and how the threat of a mosquito-borne disease outbreak has been affected by ongoing anthropogenic environmental change. José then worked as a Senior Advisor for MAF Biosecurity NZ, where he provided expert advice to the NZ government on biosecurity threats to human health.
In 2008, José joined the Liggins Institute (University of Auckland) where he has been working on paediatric research, as well as on a number of clinical trials in adolescents and adults at risk of metabolic disease. His research focuses primarily on the long-term effects of early life events (such as preterm or post-term birth) in childhood. However, José has recently been appointed as an honorary research associate at Uppsala University in Sweden, where alongside his Swedish colleagues he has been examining also the long-term effects of early life events in adulthood.
Lastly, José is currently involved in a large multi-institutional project (A Better Start) in New Zealand, with a leading role in a number of studies aiming to predict, prevent, and mitigate childhood obesity in the country.
As the senior immunologist for the Ebola and pre-erythrocytic malaria vaccine trials, I oversee the immunology on Phase I and II trials of vectored vaccines, both in the UK and in field trials in Africa. We use the chimpanzee adenovirus, ChAd63, as a priming vector and modified vaccinia virus (MVA) as a boosting vaccination and these viruses encode proteins from the organism that can elicit protective immune responses in our vaccinated volunteers.
The aim of my research is to define vaccine-induced immunological parameters that correlate with protection from malaria. I have access to samples from our volunteers that I can study using methods such as ELISPOT, flow cytometry and transcriptional profiling. By combining data from these different assays and analysing how these different measures relate to protection against malaria, I have been able to define the function and phenotype of T cells that are associated with protection in our human challenge model.
These findings can then be relayed back through the vaccine development process to improve the immunogenicity of our viral vectors for future trials and hopefully increase vaccine efficacy.
Associate Professor, Thoracic/Head and Neck Medical Oncology, Moores Cancer Center, University of California San Diego
Consulting biostatistician in the Division of Health Sciences at the University of Otago. In this role, I provide biostatistical expertise to a wide range of researchers on a large number of projects. Much of this is through collaborative relationships as a co-investigator with the remainder through more informal consulting relationships. I have particular interests in obesity research, especially in pediatric populations; nuts as a functional food; respiratory epidemiology; and sun protection. Prior to my current position I was a software metrics and machine learning researcher in the Department of Information Science at the same institution.
Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University.
Yeong Yeh Lee, MD, PhD, FACP, FRCP, FACG. He is Professor of Medicine and Consultant of Gastroenterology, Hepatology & Internal Medicine with the School of Medical Sciences, Universiti Sains Malaysia. Dr. Lee is particularly interested in neurogastroenterology & functional gastrointestinal diseases. He is also the editor of BMC Gastroenterology, Journal of Royal College of Physicians of Edinburgh (JRCPE) and Malaysian Journal of Medical Sciences (MJMS).